Your browser doesn't support javascript.
loading
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2.
Oudard, Stéphane; Culine, Stéphane; Vano, Yann; Goldwasser, François; Théodore, Christine; Nguyen, Thierry; Voog, Eric; Banu, Eugeniu; Vieillefond, Annick; Priou, Franck; Deplanque, Gaël; Gravis, Gwenaëlle; Ravaud, Alain; Vannetzel, Jean Michel; Machiels, Jean-Pascal; Muracciole, Xavier; Pichon, Marie-France; Bay, Jacques-Olivier; Elaidi, Reza; Teghom, Corine; Radvanyi, François; Beuzeboc, Philippe.
Afiliación
  • Oudard S; Department of Medical Oncology, Georges Pompidou Hospital, University Paris Descartes, Paris, France. Electronic address: stephane.oudard@egp.aphp.fr.
  • Culine S; Department of Medical Oncology, Saint Louis Hospital, Paris, France.
  • Vano Y; Department of Medical Oncology, Georges Pompidou Hospital, University Paris Descartes, Paris, France.
  • Goldwasser F; Department of Medical Oncology, Cochin Hospital, Paris, France.
  • Théodore C; Department of Medical Oncology, Foch Hospital, Suresnes, France.
  • Nguyen T; Department of Medical Oncology, Besançon University Hospital, Besançon, France.
  • Voog E; Department of Medical Oncology, Victor Hugo Clinic, Le Mans, France.
  • Banu E; Department of Medical Oncology, Georges Pompidou Hospital, University Paris Descartes, Paris, France.
  • Vieillefond A; Department of Medical Oncology, Cochin Hospital, Paris, France.
  • Priou F; Department of Oncology-Hematology, La Roche-Sur-Yon Hospital, La Roche-Sur-Yon, France.
  • Deplanque G; Department of Medical Oncology, Saint Joseph Foundation, Paris, France.
  • Gravis G; Department of Medical Oncology, Paoli Calmettes Institute, Marseille, France.
  • Ravaud A; Department of Medical Oncology, Bordeaux University Hospital, Bordeaux, France.
  • Vannetzel JM; Department of Oncology, Clinique Hartman, Neuilly-sur-Seine, France.
  • Machiels JP; Department of Medical Oncology, Saint Luc University Clinics, Catholic University of Leuven (IREC/MIRO, pole ONCO), Brussels, Belgium.
  • Muracciole X; Department of Medical Oncology, La Timone Hospital, Marseille, France.
  • Pichon MF; Oncobiology Laboratory, René Huguenin Center, St Cloud, France.
  • Bay JO; Department of Oncology, Saint Perrin Hospital, Clermont Ferrand, France.
  • Elaidi R; ARTIC Group (Association de Recherche sur les Thérapeutiques innovantes en Cancérologie), France.
  • Teghom C; ARTIC Group (Association de Recherche sur les Thérapeutiques innovantes en Cancérologie), France.
  • Radvanyi F; Molecular Oncology, Curie Institute, UMR 144, CNRS, Paris, France.
  • Beuzeboc P; Department of Medical Oncology, Curie Institute, Paris, France.
Eur J Cancer ; 51(1): 45-54, 2015 Jan.
Article en En | MEDLINE | ID: mdl-25459391
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Platino (Metal) / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Desoxicitidina / Anticuerpos Monoclonales Humanizados / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Platino (Metal) / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Desoxicitidina / Anticuerpos Monoclonales Humanizados / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido